Sensorineural Hearing Loss Clinical Trial
Official title:
Correlation of Auditory Evoked Brainstem Response Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers
Verified date | December 2019 |
Source | University Hospital "Sestre Milosrdnice" |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of the research:
Investigate the association of auditory evoked brainstem response characteristics with
salivary cortisone concentrations in noise-exposed workers.
Purpose of the research:
1. Investigate the magnitude of the amplitudes and latencies of auditory brainstem
responses.
2. Investigate the concentration of cortisone in saliva.
3. To investigate the correlation of the characteristics of auditory evoked brainstem
potentials with the age of the subjects or the length of work in noise.
4. Investigate the association of salivary cortisone concentration with subjects' age or
length of work in noise.
5. Investigate the prevalence of mild, moderate and severe hearing impairment in the 19-35
age group.
6. Investigate the relationship of hearing threshold shift with the age of the subjects or
the length of work in noise.
7. To investigate the difference in the characteristics of auditory evoked brainstem
potentials and the difference in salivary cortisone concentration between subjects with
a bilaterally normal hearing threshold (≤25 dB) at high frequencies and subjects with
unilaterally or bilaterally increased hearing threshold (> 25 dB) at high frequencies .
8. Investigate the perceived stress and psychosocial risk factors in the workplace and
their relationship to salivary cortisone concentrations.
Research Hypothesis:
There is an association between the characteristics of auditory evoked brainstem response and
salivary cortisone concentrations in noise-exposed workers.
Research participants
Inclusion criteria:
1. male and female
2. ages 19-35
3. exposure to noise level ≥ 85 dB (A) per week at the workplace
4. work in noise from 1 to 16 years
5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents
that have toxic effects on the ear (toluene, xylene and styrene)
6. unilaterally or bilaterally normal otoscopic findings
7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with
eardrum mobility of 0.3 to 1.3 mL
Exclusion criteria:
1. information about an earlier sudden hearing loss
2. information on chronic middle ear inflammation
3. information on ear surgery (except placement of ventilation tubes in the eardrum)
4. information on dizziness associated with hearing loss and noise
5. information on insomnia
6. current use of oral corticosteroids
7. bilaterally found air-bone gap greater than 15 dB
Status | Enrolling by invitation |
Enrollment | 100 |
Est. completion date | November 1, 2020 |
Est. primary completion date | November 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: 1. male and female 2. ages 19-35 3. exposure to noise level = 85 dB (A) per week at the workplace 4. work in noise from 1 to 16 years 5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene) 6. unilaterally or bilaterally normal otoscopic findings 7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL Exclusion Criteria: 1. information about an earlier sudden hearing loss 2. information on chronic middle ear inflammation 3. information on ear surgery (except placement of ventilation tubes in the eardrum) 4. information on dizziness associated with hearing loss and noise 5. information on insomnia 6. current use of oral corticosteroids 7. bilaterally found air-bone gap greater than 15 dB |
Country | Name | City | State |
---|---|---|---|
Croatia | University Hospital Center Sestre milosrdnice | Zagreb |
Lead Sponsor | Collaborator |
---|---|
University Hospital "Sestre Milosrdnice" |
Croatia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | auditory evoked brainstem response (ABR) characteristics | auditory evoked brainstem response after noise exposure | 1 day | |
Primary | salivary cortisone concentration | salivary cortisone concentration after noise exposure | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00023036 -
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
|
||
Completed |
NCT03746613 -
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
|
N/A | |
Recruiting |
NCT05568329 -
Appreciation for Music Processed by Hearing Aids
|
N/A | |
Withdrawn |
NCT05061758 -
A Trial of LY3056480 in Patients With SNLH
|
Phase 2 | |
Completed |
NCT01434446 -
The Effect of Sound Stimulation on Hearing Ability
|
N/A | |
Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
Recruiting |
NCT06053190 -
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
|
N/A | |
Completed |
NCT03718975 -
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
Recruiting |
NCT04102215 -
The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
|
N/A | |
Recruiting |
NCT04108598 -
The SeaSHeL National Prospective Cohort Study
|
||
Active, not recruiting |
NCT04750642 -
Cochlear Implant With Dexamethasone Eluting Electrode Array
|
N/A | |
Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06223724 -
Status Telemetry for Cochlear Implantations
|
||
Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
Suspended |
NCT02616172 -
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
Unknown status |
NCT01902914 -
Effectiveness of P02 Digital Hearing Aids
|
Phase 1/Phase 2 | |
Completed |
NCT00589511 -
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
|
N/A | |
Completed |
NCT03288753 -
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
|
N/A |